Serological diagnosis of nasopharyngeal carcinoma by enzyme linked immunosorbant assay: Optimization, standardization and diagnostic criteria

Chinese Medical Journal

Volumn 111, Issue 6, 1998, Pages 531-536

  Ng, M H ^a   Chen, H L ^b   Luo, R X ^a   Chan, K H ^c   Woo, P C Y ^a   Sham, J S T ^a   Huang, J ^a   Seto, W H ^c   Smith, P ^d   Griffin, B E ^d  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHANTOU UNIVERSITY   (China)

^c QUEEN MARY HOSPITAL   (Hong Kong)

^d IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; VIRUS ANTIBODY;

ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGY; NASOPHARYNX TUMOR; SENSITIVITY AND SPECIFICITY; SEROLOGY; STANDARD; VIROLOGY;

ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HUMANS; NASOPHARYNGEAL NEOPLASMS; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 0032081855     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Henle W, Henle G, Ho HC, et al. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst 1970; 44: 225.
2. Henle G, Henle W. Epstein-Barr virus specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 1976; 17: 1.
3. Ho HC, Kwan HC, Ng MH, et al. Serum IgA antibodies to Epstein-Barr virus capsid antigen preceding symptoms of nasopharyngeal carcinoma. Lancet 1978; 1: 436.
4. Zeng Y, Zang LG, Li HY, et al. Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int J Cancer 1982; 29: 139.
5. Sham JST, Wei WI, Zong YS, et al. Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy. Lancet 1990; 335: 371.
6. Zeng Y, Zhang LG, Wu YC, et al. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody- positive persons in Wuzhou City, China. Int J Cancer 1985; 36: 545.
7. Cheng HM, Foong YT, Mathew A, et al. Screening for nasopharyngeal carcinoma with an ELISA using the Epstein-Barr virus nuclear antigen, EBNA 1: a complementary test to the IgA/VCA. immunofluorescence assay. J Virol Methods; 42: 45.
8. Smith DB, Johnson KS. Single-step purification of polypeptides expressed in Escherichia Coli as fusion with glutathione S-transferase. Gene 1988; 67: 31.